Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Cyclophosphamide and Sirolimus
DRUG
2 trials
Sponsors
University of Michigan Rogel Cancer Center
, Hackensack Meridian Health
Conditions
Graft Versus Host Disease
Osteosarcoma
Phase 1
In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus
Terminated
NCT01453140
Hackensack Meridian Health
Graft Versus Host Disease
Start: 2011-08-01
End: 2012-07-01
Updated: 2026-04-08
Phase 2
A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma
Completed
NCT00743509
University of Michigan Rogel Cancer Center
Osteosarcoma
Start: 2008-08-31
End: 2012-09-30
Updated: 2015-09-28